EUVIMEDEUVIMED entdecken
Crossref

The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients.

SECI Oncology Journal · 18.08.2026 · 14 (3) · 144-152

DOI: 10.21608/secioj.2026.523064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SECI Oncology Journal, online erschienen am 18.08.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients. SECI Oncology Journal, 14(3), 144-152. https://doi.org/10.21608/secioj.2026.523064

Vancouver

The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients. SECI Oncology Journal. 2026;14(3):144-152. doi:10.21608/secioj.2026.523064

BibTeX
@article{euvimed2026,
  title = {The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients},
  journal = {SECI Oncology Journal},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {144--152},
  doi = {10.21608/secioj.2026.523064}
}
Kostenlos starten →